September 22, 2021
Boston Scientific cancer treatment shown to be effective in clinical trial
Photo | Boston Scientific
Boston Scientific's TheraSphere Y-90 Glass Microspheres
By Katherine Hamilton
Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.
The trial demonstrated the treatment was both safe and effective for patients with colorectal cancer, which affects 1.9 million people each year, according to the press release from Boston Scientific.
TheraSpere delivers treatment directly to liver tumors, minimizing radiation exposure to health tissue, whereas the most common therapies for colorectal cancer include surgery and systemic chemotherapy, per the announcement.
The U.S. Food & Drug Administration approved TheraSphere for hepatocellular carcinoma earlier this year.
WBJ Web Partners
Most Recent
Most Recent
0 Comments